Boston Scientific
From Wikipedia, the free encyclopedia
| Boston Scientific | |
 |
|
| Type | Public |
|---|---|
| Founded | 1979 |
| Headquarters | Natick, Massachusetts |
| Key people | John Abele, Founder & Director Peter Nicholas, Founder & Chairman James Tobin, CEO Paul LaViolette, COO |
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is well known for the development of the Taxus Stent, a drug-coated stent which is used to open clogged arteries.
Boston Scientific's main competitors are Johnson & Johnson and Medtronic. The company recently acquired longtime competitor Guidant for approximately $28 billion. The former Guidant was split between BSC and Abbott Laboratories[1].
